Attridge S R, Dearlove C, Beyer L, van den Bosch L, Howles A, Hackett J, Morona R, LaBrooy J, Rowley D
Enterovax Ltd., c/o Department of Microbiology and Immunology, University of Adelaide, Adelaide, Australia.
Infect Immun. 1991 Jul;59(7):2279-84. doi: 10.1128/iai.59.7.2279-2284.1991.
EX645 is a derivative of Salmonella typhi Ty21a which carries a plasmid specifying production of Vibrio cholerae O antigen. When cultured with exogenous galactose to overcome the galE defect of the vector, EX645 also synthesizes S. typhi O antigen, and this can result in the masking of the shorter V. cholerae O antigen on the bacterial surface. To determine whether the potential for such masking at least partly underlies the inconsistency of anti-V. cholerae responses elicited by EX645, a derivative of this strain has been isolated, characterized, and tested for immunogenicity in human volunteers. EX880 has an rfb defect which prevents synthesis of S. typhi O antigen, and consequently V. cholerae O antigen is still detectable on the surface of the clone following growth in the presence of galactose. Compared with EX645, EX880 more consistently elicited significant rises in serum bactericidal antibody levels, although individual responses within a cohort still varied widely.
EX645是伤寒沙门氏菌Ty21a的衍生物,它携带一个质粒,该质粒可指定霍乱弧菌O抗原的产生。当与外源性半乳糖一起培养以克服载体的galE缺陷时,EX645也会合成伤寒沙门氏菌O抗原,这可能导致细菌表面较短的霍乱弧菌O抗原被掩盖。为了确定这种掩盖的可能性是否至少部分是EX645引发的抗霍乱弧菌反应不一致的原因,已分离出该菌株的一种衍生物,对其进行了表征,并在人类志愿者中测试了其免疫原性。EX880存在rfb缺陷,可阻止伤寒沙门氏菌O抗原的合成,因此在半乳糖存在下生长后,霍乱弧菌O抗原在克隆表面仍可检测到。与EX645相比,EX880更一致地引起血清杀菌抗体水平的显著升高,尽管同一队列中的个体反应仍有很大差异。